These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 21088349)
1. Successful blood pressure control with additive administration of eplerenone, an aldosterone receptor blocker, in a patient with bilateral renovascular hypertension treated with angioplasty. Ibuki C; Kawamata H; Seino Y; Mizuno K Intern Med; 2010; 49(22):2455-9. PubMed ID: 21088349 [TBL] [Abstract][Full Text] [Related]
2. Assessment of the novel selective aldosterone blocker eplerenone using ambulatory and clinical blood pressure in patients with systemic hypertension. White WB; Carr AA; Krause S; Jordan R; Roniker B; Oigman W Am J Cardiol; 2003 Jul; 92(1):38-42. PubMed ID: 12842242 [TBL] [Abstract][Full Text] [Related]
3. Effects of eplerenone on heart and kidney in two-kidney, one-clip rats. Hao L; Kanno Y; Fukushima R; Watanabe Y; Ishida Y; Suzuki H Am J Nephrol; 2004; 24(1):54-60. PubMed ID: 14707436 [TBL] [Abstract][Full Text] [Related]
4. Effects of eplerenone on nephrotic syndrome in a patient with renovascular hypertension. Suzuki J; Otsuka F; Inagaki K; Tanabe K; Tsukamoto N; Miyoshi T; Nakamura E; Ogura T; Kumagai I; Makino H Hypertens Res; 2011 Mar; 34(3):404-6. PubMed ID: 21160478 [No Abstract] [Full Text] [Related]
5. Treatment of severe hypertension in a 14-year-old child: Successful blood pressure control with additive administration of captopril, an angiotensin-converting enzyme inhibitor, in a patient with bilateral renovascular hypertension. Zhang X; Xu Y; Chen X; Wang S; Li X; Yan X Clin Exp Hypertens; 2017; 39(7):587-591. PubMed ID: 28621587 [TBL] [Abstract][Full Text] [Related]
6. Effect of eplerenone on blood pressure and the renin-angiotensin-aldosterone system in oligo-anuric chronic hemodialysis patients - a pilot study. Shavit L; Neykin D; Lifschitz M; Slotki I Clin Nephrol; 2011 Nov; 76(5):388-95. PubMed ID: 22000559 [TBL] [Abstract][Full Text] [Related]
7. Effects of eplerenone versus losartan in patients with low-renin hypertension. Weinberger MH; White WB; Ruilope LM; MacDonald TM; Davidson RC; Roniker B; Patrick JL; Krause SL Am Heart J; 2005 Sep; 150(3):426-33. PubMed ID: 16169319 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of mineralocorticoid receptors in mild to moderate arterial hypertension. Pelliccia F; Rosano G; Patti G; Volterrani M; Greco C; Gaudio C Int J Cardiol; 2015 Dec; 200():8-11. PubMed ID: 25466561 [TBL] [Abstract][Full Text] [Related]
9. Clinical effects of eplerenone, a selective aldosterone blocker, in Japanese patients with essential hypertension. Sato A; Fukuda S J Hum Hypertens; 2010 Jun; 24(6):387-94. PubMed ID: 19865106 [TBL] [Abstract][Full Text] [Related]
10. Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study. Pitt B; Reichek N; Willenbrock R; Zannad F; Phillips RA; Roniker B; Kleiman J; Krause S; Burns D; Williams GH Circulation; 2003 Oct; 108(15):1831-8. PubMed ID: 14517164 [TBL] [Abstract][Full Text] [Related]
11. Long-term safety and efficacy of the selective aldosterone blocker eplerenone in patients with essential hypertension. Burgess ED; Lacourcière Y; Ruilope-Urioste LM; Oparil S; Kleiman JH; Krause S; Roniker B; Maurath C Clin Ther; 2003 Sep; 25(9):2388-404. PubMed ID: 14604739 [TBL] [Abstract][Full Text] [Related]
12. Eplerenone: a selective aldosterone receptor antagonist for hypertension and heart failure. Moore TD; Nawarskas JJ; Anderson JR Heart Dis; 2003; 5(5):354-63. PubMed ID: 14503934 [TBL] [Abstract][Full Text] [Related]
18. Anti-albuminuric effect of the aldosterone blocker eplerenone in non-diabetic hypertensive patients with albuminuria: a double-blind, randomised, placebo-controlled trial. Ando K; Ohtsu H; Uchida S; Kaname S; Arakawa Y; Fujita T; Lancet Diabetes Endocrinol; 2014 Dec; 2(12):944-53. PubMed ID: 25466242 [TBL] [Abstract][Full Text] [Related]
19. Eplerenone: a review of its use in essential hypertension. Croom KF; Perry CM Am J Cardiovasc Drugs; 2005; 5(1):51-69. PubMed ID: 15631538 [TBL] [Abstract][Full Text] [Related]
20. The use of aldosterone receptor blockers in the treatment of hypertension. Weinberger MH J Clin Hypertens (Greenwich); 2004 Nov; 6(11):632-5. PubMed ID: 15538096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]